XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 220 filers reported holding XENON PHARMACEUTICALS INC in Q1 2024. The put-call ratio across all filers is 0.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $14,059,794 | -6.2% | 360,600 | +3.6% | 5.74% | -3.3% |
| Q1 2024 | $14,981,400 | +12.0% | 348,000 | +19.8% | 5.93% | -34.7% |
| Q4 2023 | $13,382,042 | +71.8% | 290,535 | +27.4% | 9.08% | +123.6% |
| Q3 2023 | $7,788,480 | -11.3% | 228,000 | 0.0% | 4.06% | -38.9% |
| Q2 2023 | $8,778,000 | +166.0% | 228,000 | +5.6% | 6.64% | +667.2% |
| Q3 2021 | $3,300,000 | +14.3% | 216,000 | +39.4% | 0.87% | +29.4% |
| Q2 2021 | $2,886,000 | – | 155,000 | – | 0.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 3,516,851 | $44,101,000 | 2.72% |
| Parkman Healthcare Partners LLC | 590,267 | $7,402,000 | 2.08% |
| ACUTA CAPITAL PARTNERS, LLC | 517,500 | $6,489,000 | 1.88% |
| Soleus Capital Management, L.P. | 250,897 | $3,146,000 | 1.79% |
| DAFNA Capital Management LLC | 346,535 | $4,346,000 | 1.25% |
| KNOTT DAVID M | 169,000 | $2,119,000 | 1.16% |
| Ghost Tree Capital, LLC | 325,000 | $4,076,000 | 1.08% |
| Avoro Capital Advisors LLC | 2,800,000 | $35,112,000 | 0.69% |
| NEA Management Company, LLC | 992,107 | $12,441,000 | 0.50% |
| Orbimed Advisors | 2,497,917 | $31,324,000 | 0.44% |